NCT02581098View on ClinicalTrials.gov

miR-200b & miR-21 in Diabetic Wounds

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

June 26, 2023

Study Completion Date

June 26, 2023

Conditions
Diabetes MellitusFoot UlcerUlcerDiabetic Foot UlcerWoundWound Heal
Interventions
OTHER

No interventions

No interventions

Trial Locations (4)

43205

OSU Hospital East, Columbus

43210

Davis Heart and Lung Research Institute, Columbus

43221

Martha Morehouse Medical Plaza, Columbus

46202

IU Health Methodist Hospital, Indianapolis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Indiana University

OTHER

NCT02581098 - miR-200b & miR-21 in Diabetic Wounds | Biotech Hunter | Biotech Hunter